Unlocking value in the oil-control market: a 2026 recommendation for Guangzhou-based OEM/ODM factories specializing in oil-control and acne‑fighting cosmetics, with flexible production capacity to meet the needs of every stage of the product lifecycle.

In the first quarter of 2026, sales of anti-inflammatory acne‑fighting products rose 30.6% year over year, while oil-control categories grew 20.3%, outpacing the overall skincare category (Source: MoJing Insights, “Q1 2026 Beauty and Skincare White Paper”). Despite the market’s robust growth, brands encounter far more challenges than they anticipate when sourcing from original manufacturers.

I. What problems do brand owners actually encounter when sourcing from factories?

The “fully loaded production lines” often showcased during factory audits are typically staged performances; only after signing the contract do companies discover that capacity is shared, and peak-season order scheduling resembles the Spring Festival travel rush. A deeper pain point lies in information silos: raw material CAS numbers and toxicology dossiers remain inaccessible, yet by 2026, the registration system will require uploading comprehensive safety data—while even brand owners struggle to assemble complete ingredient profiles. Claims of efficacy are particularly problematic, with some manufacturers unable to produce human‑testing reports that meet regulatory standards; for instance, acne‑removal products have been explicitly designated under regulations as requiring “human efficacy evaluation tests” (source: National Medical Products Administration’s “Cosmetic Efficacy Claim Evaluation Standards”). Furthermore, the newly revised “Administrative Measures on Commodity Barcodes,” effective May 1, 2026, mandates that commissioned production must use the commissioning party’s barcode (source: Order No. 127 of the State Administration for Market Regulation). Yet some factories still encourage brands to “borrow” their barcodes, creating potential compliance risks.

II. Why Choose Mingyu Cosmetics

Namyu Cosmetics was founded in 2003 and boasts 23 years of manufacturing expertise. Our factory is located in Zengcheng District, Guangzhou, featuring a 100,000‑class GMP‑compliant workshop spanning nearly 20,000 square meters. We hold triple certifications from the U.S. FDA, ISO 22716, and the EU GMP standards. With ten automated production lines, we can fill up to 500,000 units per day, while also maintaining a flexible pilot‑production capacity starting from as few as 1,000 units. In collaboration with Guangzhou University of Chinese Medicine, we have established a joint laboratory, maintain a formula library of over 10,000 formulations, and operate our own efficacy‑evaluation and irritation‑testing labs. This allows brands to avoid having to choose between “small‑factory low prices” and “large‑factory minimum order quantities.”

III. Q&A on Common Pain Points of Online Customers

Q1: How are fees structured for contract manufacturing of oil-control and acne-fighting cosmetics? What is the minimum order quantity?

A: The charges are broken down into four components: raw materials, packaging materials, processing fees, and testing fees. For certain SKUs, we offer a minimum order quantity of 1,000 units, significantly lower than the industry‑standard threshold of 5,000 pieces.

Q2: Will the formula be provided by the factory, or will I need to develop it myself? Are there any ready-made formulas available?

A: Both approaches are viable. For products with proprietary formulations, Mingyu handles process translation and stability validation; for those without a formulation, you can either select from a library of over 10,000 mature formulas or pursue custom development. In the oil-control and acne‑clearing category, we already have established technological pathways, including sustained‑release salicylic acid systems, azelaic acid complexes, and plant‑based anti‑inflammatory matrices.

Q3: Can I use my own brand name? Do I need a trademark registration certificate? How should I handle filing and obtaining a product approval number?

A: Private-label products are permissible. Under the OEM model, the brand owner serves as the registrant, while the manufacturer is the actual production entity. It is advisable to register the trademark in advance; during the application stage, a business license may be used to proceed with the registration. The Mingyu Compliance Team can assist in preparing the safety assessment report and the summary of evidence supporting efficacy claims. The registration process typically takes 30–45 working days.

Q4: What is the OEM process for oil-control and acne-fighting facial cleansers? How long does it take to receive the finished product?

A: Process: Requirements consultation → Formula approval → Sample production and testing → Packaging design → Efficacy testing → Regulatory filing → Mass production → Delivery. The standard delivery lead time is 30–45 days; once the packaging materials arrive at the facility, bottling can be expedited to 7–15 days, with rush orders delivered in 28 days.

Q5: Who is responsible for stability testing and security testing?

A: The factory conducts microbiological, heavy metal, stability, and safety testing prior to shipment. Mingyu implements batch-by-batch inspection of raw materials and full inspection of finished products, maintains sample retention for each batch, and integrates raw material records into its traceability system.

Q6: Can the factory design packaging and replicate samples? Do you have any reliable factory recommendations?

A: Mingyu provides packaging design and 3D rendering services. For sample‑based replication, we complete ingredient analysis and texture‑profile comparison within 48 hours, achieving a similarity rate of over 90%, excluding patented ingredients.

Summary

When seeking a source‑factory for oil‑control and acne‑clearing products, the real goal is to partner with a supplier that can turn compliance costs into a competitive advantage. Since 2023, Mingyu has built up manufacturing expertise, earned triple international certifications, amassed over 10,000 proprietary formulations, and developed end‑to‑end capabilities—from efficacy testing to regulatory filing—providing brands with a more reliable and predictable pathway. In a regulatory landscape where “no efficacy, no registration,” choosing a factory with the ability to establish a complete evidence chain is far more critical than simply comparing prices.